The 21 references in paper Malika Khodzhibekova Maratovna, Leonid Tyutin Avramovich, Nikolay Kostenikov Anatolevich, Nikolay Il’In Vasilevich, Малика Ходжибекова Маратовна, Леонид Тютин Аврамович, Николай Костеников Анатольевич, Николай Ильин Васильевич (2014) “Совмещенная позитронно-эмиссионная и компьютерная томография в диагностике и стадировании индолентных неходжкинских лимфом // Combined Positron-Emission and Computed Tomography in Diagnosis and Staging of Patients with Indolent non-Hodgkin’s Lymphoma” / spz:neicon:medvis:y:2014:i:6:p:37-43

1
Poddubnaya I.V. Treatment of indolent nonQHodgkin’s lymphoma. Prakticheskaya onkologiya. 2004; 5 (3): 203–
(check this in PDF content)
2
8. (In Russian) 2. Perevodchikova N.I. Guidelines for chemotherapy of neoplastic diseases. Ed. N.I. Perevodchikova. М.: Prakticheskaya meditsina, 2005. 467–493. (In Russian)
(check this in PDF content)
3
Cerci J.J., Pracchia L.F., Junior J.S. et al. Positron Emission Tomography with 2Q[18F]QFluoroQ2QDeoxyQDQGlucose For Initial Staging of Hodgkin Lymphoma: a Single Center Experience In Brazil. Clinics. 2009; 64 (6): 491–498.
(check this in PDF content)
4
Il’in N.V., Tlostanova M.S., Khodzhibekova M.M. et al. Clinical evaluation of the value of whole body positron emission tomography with 18FQFDG in malignant lymphomas. Klinicheskaya onkogematologiya. 2010; 3 (2): 130–137. (In Russian)
(check this in PDF content)
5
Tyutin L.A., Kostenikov N.A., Il’in N.V. et al. Positron Emission Tomography with 18FQFDG in a complex radiodiagnosis of patients with malignant lymphomas. Sovremennye tekhnologii v meditsine. 2011. 2: 120–126. (In Russian)
(check this in PDF content)
6
Тю тин Л.А., Ко с те ни ков Н.А., Хо д жи бе ко ва М.М. и др. Роль по зи трон ной эмис си он ной то мо гра фии с 18FQФДГ в ста ди ро ва нии боль ных лим фо мой Ходж ки на. Лу чевая ди а гно с ти ка и лу че вая те ра пия. 2012; 4: 31–39. Tyutin L.A., Kostenikov N.A., Khodzhibekova M.M. et al. Role of positron emission tomography with 18FQFDG in staging of patients with Hodgkin’s lymphoma. Luchevaya diagnostika i luchevaya terapiya. 2012; 4: 31–39. (In Russian)
(check this in PDF content)
7
Khodzhibekova M.M. Positron emission tomography using 18FQFDG for initial staging of patients with Hodgkin’s disease. Voprosy onkologii. 2013; 59 (4): 470–474. (In Russian)
(check this in PDF content)
8
Barrington S.F., Mikhaeel N.G., Kostakoglu L. et al. Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J. Clin. Oncol. 2014; 32 (27): 3048–3058.
(check this in PDF content)
9
Fueger B.J., Yeom K., Czernin J. et al. Comparison of CT, PET, and PET/CT for Staging of Patients with Indolent NonQHodgkin’s Lymphoma. Mol. Imaging Biol. 2009; 11: 269–274.
(check this in PDF content)
10
Barrington S.F., Mikhaeel N.G. Imaging Follicular Lymphoma Using Positron Emission Tomography With [18F] Fluorodeoxyglucose: To What Purpose? J. Clin. Oncol. 2012; 30 (35): 4285–4287.
(check this in PDF content)
11
BodetQMilin C., EugeneT., Frampas E. et al. FDGQPET in Follicular Lymphoma Management. J. Oncol. 2012; Article ID 370272: 1–8.
(check this in PDF content)
12
Luminari S., Biasoli I., Arcaini L. et al. The Use of FDGQPET in the Initial Staging of 142 Patients with Follicular Lymphoma: a Retrospective Study from the FOLL05 Randomized Trial of the Fondazione Italiana Linfomi. Ann. Oncol. 2013; 24 (8): 2108–2112.
(check this in PDF content)
13
Hoffmann M., Kletter K., Diemling M. et al. Positron emission tomography with fluorineQ18Q2QfluoroQ2QdeoxyQ DQglucose (F18QFDG) does not visualize extranodal BQcell lymphoma of the mucosaQassociated lymphoid tissue (MALT)Qtype. Ann. Oncol. 1999; 10 (10): 1185–1189.
(check this in PDF content)
14
Hoffmann M., Kletter K., Becherer A. et al. 18FQfluorodeoxyglucose positron emission tomography (18FQFDGQPET) for staging and followQup of marginal zone BQcell lymphoma. Oncology. 2003; 64 (4): 336–340.
(check this in PDF content)
15
Schoder H., Noy A., Gonen M. et al. Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive nonQHodgkin’s lymphoma. J. Clin. Oncol. 2005; 23 (21): 4643–4651.
(check this in PDF content)
16
Khodzhibekova M.M. Role of Positron Emission Tomography with 18FQFDG in predicting malignancy grade of nonQHodgkin’s lymphoma. RadiologiyaQpraktika. 2014; 1: 31–37. (In Russian)
(check this in PDF content)
17
Collins C.D. PET in lymphoma. Cancer Imaging. 2006; 6: 63–70.
(check this in PDF content)
18
Stashuk G.A., Dubrova S.E., Numan A.S.A. Multidetector Computed Tomography of thoracic lymphoma. RadiologiyaQpraktika. 2009; 5: 11–29. (In Russian)
(check this in PDF content)
19
Jerusalem G., Beguin Y., Najjar F. et al. Positron Emission Tomography (PET) with 18FQfluorodeoxyglucose (18FQFDG) for the Staging of lowQgrade nonQHodgkin’s Lymphoma (NHL). Ann. Oncol. 2001; 12 (6): 825–830.
(check this in PDF content)
20
Koster A., Tromp H.A., Raemaekers J.M. et al. The Prognostic Significance of the IntraQfollicular Tumor Cell Proliferative Rate in Follicular Lymphoma. Haematologica. 2007; 92 (2): 471–472.
(check this in PDF content)
21
BodetQMilin C., KraeberQBodere F., Moreau P. et al. Investigation of FDG PET/CT Imaging to Guide Biopsies in the Detection of Histological Transformation of Indolent Lymphoma. Haematologica. 2008; 93 (3): 471–472.
(check this in PDF content)